Jump to main content.


Octabromodiphenyl ether Quickview (CASRN 32536-52-0)

Health assessment information on a chemical substance is included in IRIS only after a comprehensive review of toxicity data by U.S. EPA health scientists from several Program Offices, Regional Offices, and the Office of Research and Development.

Disclaimer: This QuickView represents a snapshot of key information. We suggest that you read the IRIS Summary to put this information into complete context.

For definitions of terms in the IRIS Web site, refer to the IRIS Glossary.

Status of Data for Octabromodiphenyl ether

File First On-Line: 03/31/1987; Last Significant Revision: 08/01/1990

Category (section)
Status
Last Revised
Oral RfD Assessment On-line 08/01/1990
Inhalation RfC Assessment No data
Carcinogenicity Assessment On-line 08/01/1990
Synonyms
  • Benzene, 1,1'-oxybis-, octabromo deriv.
  • Bromkal 79-8de
  • DE 71
  • DE 79
  • FR 143
  • Octabromodiphenyl ether
  • Phenyl ether, octabromo deriv.
  • Tardex 80
  • 32536-52-0
Octabromodiphenyl ether Source Documents
Chronic Health Hazard Assessments for Noncarcinogenic Effects

Reference Dose for Chronic Oral Exposure (RfD)

Critical Effect
Point of Departure*
UF RfD
Induction of hepatic enzymes; liver histopathology NOAEL : 2.51 mg/kg-day 1000 3 x10-3 mg/kg-day

* The Point of Departure listed serves as a basis from which the Oral RfD was derived. See Discussion of Conversion Factors and Assumptions for more details.

Top of page


Reference Concentration for Chronic Inhalation Exposure (RfC)

Not Assessed under the IRIS Program.

Top of page

Carcinogenicity Assessment for Lifetime Exposure
  • Weight-of-Evidence Characterization
    • D (Not classifiable as to human carcinogenicity)
  • Weight-of-Evidence Narrative:
    • No human data and no animal data available.
    • This may be a synopsis of the full weight-of-evidence narrative. See IRIS Summary.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure

  • Not Assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure

  • Not Assessed under the IRIS Program.

Top of page


Recent Additions | Advanced Search | IRIS Home | Environmental Assessment | Research


Local Navigation


Jump to main content.